The treatment of stage III non–small-cell lung cancer has evolved over the last two decades,
with combined-modality therapy the current standard of care. As a result, intermediate and …

Radiation was until recently the key and only modality for the routine treatment of locally
advanced cervical carcinoma. However after years of studying multi-modality treatments as …

Background Brain metastases (BM) are frequent sites of initial failure in patients with locally
advanced nonsmall cell lung cancer (LAD-NSCLC) undergoing multimodality treatments …

Following definitive chemoradiation therapy, 24%-35% of patients with locally advanced non–
small cell lung cancer have recurrence. We aimed to evaluate the feasibility of salvage …

BACKGROUND: Isolated local relapse occurs in 24% to 35% of patients after definitive
chemoradiation for locally advanced non-small cell lung cancer. Although originally …

Background Honokiol is a major bioactive compound extracted from Magnolia. The present
study was designed to determine whether liposomal honokiol has the antitumor activity …

PURPOSE: To compare gemcitabine and cisplatin (GC) with cisplatin (C) concurrent with
radiotherapy in International Federation of Gynecology and Obstetrics Stage IB2, IIA, and IIB …

BACKGROUND: Pneumonectomy after high-dose radiotherapy and concurrent
chemotherapy has been associated with high operative mortality. Therefore, most induction …

Newcastle disease virus (NDV), an avian paramyxovirus, has a potential oncolytic effect that
may be of significance in the treatment of a variety of cancer diseases. An attenuated …

BACKGROUND. Excision repair cross‐complementation Group 1 (ERCC1) overexpression
is associated with resistance to cisplatin‐based chemotherapy in patients with nonsmall‐cell …